コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 , or introduction of the Akt and mTOR target eukaryotic translation initiation factor 4E.
2 tion initiation factor 4E-binding protein 1/ eukaryotic translation initiation factor 4E (4EBP1/eIF4E
3 UPAR in monocytic cells is also regulated by eukaryotic translation initiation factor 4E, a second ke
4 ition or blockade of its downstream effector eukaryotic translation initiation factor 4E activity equ
5 ransition machinery, decreases expression of eukaryotic translation initiation factor 4E and cyclin D
6 in HuR and the posttranscriptional regulator eukaryotic translation initiation factor 4E as two possi
7 ts demonstrate the importance of the p38-MNK-eukaryotic translation initiation factor 4E axis in TNF
8 apamycin (mTOR)-dependent phosphorylation of eukaryotic translation initiation factor 4E binding prot
9 ibosomal protein S6, S6 kinase 1 (S6K1), and eukaryotic translation initiation factor 4E binding prot
11 t, mammalian target of Rapamycin (mTOR), and eukaryotic translation initiation factor 4E binding prot
12 eam targets ribosomal S6 kinase 1 (S6K1) and eukaryotic translation initiation factor 4E binding prot
13 regulators, including p70-S6 kinase and the eukaryotic translation initiation factor, 4E binding pro
14 hosphorylates and inactivates members of the eukaryotic translation initiation factor 4E-binding (eIF
15 rough an RNA-RNA interaction and an adjacent eukaryotic translation initiation factor 4E-binding 3'CI
16 kissing-loop T-shaped structure (kl-TSS) and eukaryotic translation initiation factor 4E-binding Pani
18 ing studies revealed hyperphosphorylation of eukaryotic translation initiation factor 4E-binding prot
19 properties: first, it preferentially targets eukaryotic translation initiation factor 4E-binding prot
21 ating p70S6K/ribosomal protein S6 (RPS6) and eukaryotic translation initiation factor 4E-binding prot
22 omplex 1, ribosomal protein S6 kinase 1, and eukaryotic translation initiation factor 4E-binding prot
24 ulation of the translation repressor, 4E-BP (eukaryotic translation initiation factor 4E-binding prot
25 tion of mammalian target of rapamycin (mTOR)/eukaryotic translation initiation factor 4E-binding prot
26 ncoding cell-cycle regulators via the mTORC1/eukaryotic translation initiation factor 4E-binding prot
27 pamycin (mTOR) signaling pathway to preserve eukaryotic translation initiation factor 4E-binding prot
28 ase (Chk) 1 serine 345 (S345), Chk 2 S33/35, eukaryotic translation initiation factor 4E-binding prot
29 anslation at a different level by inhibiting eukaryotic translation initiation factor 4E-binding prot
30 mitochondrial structure, and accumulation of eukaryotic translation initiation factor 4E-binding prot
31 Ser 79, tuberous sclerosis 2 at Thr 1462 and eukaryotic translation initiation factor 4E-binding prot
32 a constitutively active alternate substrate, eukaryotic translation initiation factor 4E-binding prot
33 ammalian target of rapamycin (mTOR)-directed eukaryotic translation initiation factor 4E-binding prot
34 tion of the 40S ribosomal protein S6 and the eukaryotic translation initiation factor 4E-binding prot
35 ribosomal protein S6 kinases (S6Ks) and the eukaryotic translation initiation factor 4E-binding prot
36 Discovery of oocyte-specific eukaryotic translation initiation factor 4E distinguishe
38 onal repressor that inhibits the function of eukaryotic translation initiation factor 4E (eIF-4E).
39 f acute myeloid leukemia (AML) by regulating eukaryotic translation initiation factor 4E (eIF4E) acti
41 rough the binding of the cap-binding protein eukaryotic translation initiation factor 4E (eIF4E) and
42 s been found to be based on mutations in the eukaryotic translation initiation factor 4E (eIF4E) and
43 ERK activation stimulated phosphorylation of eukaryotic translation initiation factor 4E (eIF4E) and
44 of translation engage mRNA that is bound by eukaryotic translation initiation factor 4E (eIF4E) at t
45 se interacting serine/threonine kinase (MNK)-eukaryotic translation initiation factor 4E (eIF4E) axis
49 EITC caused an increase in expression of the eukaryotic translation initiation factor 4E (eIF4E) bind
50 hrough simultaneous activation of mTORC1 and eukaryotic translation initiation factor 4E (eIF4E) by N
55 Here we show that a functional reduction of eukaryotic translation initiation factor 4E (eIF4E) in D
56 ow that genetically increasing the levels of eukaryotic translation initiation factor 4E (eIF4E) in m
65 ling along the mTOR-dependent S6K1 or 4E-BP1/eukaryotic translation initiation factor 4E (eIF4E) path
70 clear retention of PCBP1, recruitment to the eukaryotic translation initiation factor 4E (eIF4E) prom
71 hibitor of kappaB alpha (IkappaB-alpha) S32, eukaryotic translation initiation factor 4E (eIF4E) S209
72 down-regulated by JNK2alpha2APF, among which eukaryotic translation initiation factor 4E (eIF4E) show
76 tion-dissociation of the cap-binding protein eukaryotic translation initiation factor 4E (eIF4E) with
80 nclude ribosomal protein S6 kinase 1 (S6K1), eukaryotic translation initiation factor 4E (eIF4E), and
83 action of Dcp1p and the cap binding protein, eukaryotic translation initiation factor 4E (eIF4E), in
84 rs often overexpress the cap binding protein eukaryotic translation initiation factor 4E (eIF4E), lea
85 The rate-limiting factor for translation is eukaryotic translation initiation factor 4E (eIF4E), whi
86 K signals to Mnk1 lead to phosphorylation of eukaryotic translation initiation factor 4E (eIF4E), whi
87 mRNA translation by promoting sumoylation of eukaryotic translation initiation factor 4E (eIF4E), whi
89 ing means to target a specific oncogene, the eukaryotic translation initiation factor 4E (eIF4E), wit
90 bserved that Eap1p, which is a member of the eukaryotic translation initiation factor 4E (eIF4E)-bind
91 rgistically inhibited phosphorylation of the eukaryotic translation initiation factor 4E (eIF4E)-bind
92 tioning in mice, we investigated the role of eukaryotic translation initiation factor 4E (eIF4E)-eIF4
93 K and AKT signaling are required to activate eukaryotic translation initiation factor 4E (eIF4E)-init
96 erminal domain, which displays similarity to eukaryotic translation initiation factor 4E (eIF4E).
97 A translation is dependent on mTORC1 and the eukaryotic translation initiation factor 4E (eIF4E).
98 ulation of ribosomal p70S6 kinase (S6K1) and eukaryotic translation initiation factor-4E (eIF4E) bind
100 reased sensitivity to dominant inhibition of eukaryotic translation initiation factor 4E function.
102 and also reduce the level of phosphorylated eukaryotic translation initiation factor 4E in the tumor
103 slational checkpoint, and phosphorylation of eukaryotic translation initiation factor 4E is induced b
104 in CD4 T cells through the activation of the eukaryotic translation initiation factor 4E/MAPK-interac
105 s HuR) regulates the alternative splicing of eukaryotic translation initiation factor 4E nuclear impo
106 ammalian target of rapamycin, phosphorylated eukaryotic translation initiation factor 4E, phosphoryla
107 s of Akt, mammalian target of rapamycin, and eukaryotic translation initiation factor 4E phosphorylat
108 A trend for an increase of eukaryotic translation initiation factor 4E phosphorylat
109 mport factor 1 (Eif4enif1), which encodes an eukaryotic translation initiation factor 4E transporter
110 pathway, and ribosomal protein S6 kinase and eukaryotic translation initiation factor 4E, two importa
111 p38 MAPK, MAPK-interacting kinase (MNK), and eukaryotic translation initiation factor 4E, which is a
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。